Wave Life Sciences

Yahoo Finance • 15 days ago

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Pa... Full story

Yahoo Finance • 26 days ago

Arrowhead (ARWR) Rated Buy on Metabolic Pipeline Potential

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) ranks among the most profitable biotech stocks to buy now. Following comments on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)’s obesity and metabolic illness initiatives, TD Cowen reiterated its... Full story

Yahoo Finance • last month

Wave Life Sciences Ltd. (WVE) Sees Strong Buy Rating From Analysts

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The company’s stock registered a 22.39% growth from a year ago and a 53.04% percent decline year-to-date. Based on analyst consen... Full story

Yahoo Finance • last month

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE)

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 8 Healthcare Stocks Insiders Are Buying. On April 7, 2026, RBC Capital analyst Luca Issi lowered the price target on Wave Life Sciences Ltd. (NASDAQ:WVE) to $15 from $27 and maintained an... Full story

Yahoo Finance • 2 months ago

Is This Weight Loss Drug Stock a Buy on the Dip?

Key Points Wave Life Sciences' shares dropped after its weight loss candidate failed to impress in a phase 1 study. However, this product could actually be successful if it can confirm its recent phase 1 results. 10 stocks we like better... Full story

Yahoo Finance • 2 months ago

Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints

Wave Life Sciences(NASDAQ:WVE), developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank after disappointing higher-dose WVE-007 obesity data underperformed the lower dose.... Full story

Yahoo Finance • 2 months ago

Stock market today: Dow, S&P 500 sink, Nasdaq enters correction territory as oil spikes amid Iran war

US stocks sank on Thursday, with Big Tech and semiconductor stocks leading the sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. The tech-heavy Nasdaq... Full story

Yahoo Finance • 2 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as Big Tech slides and oil spikes amid Iran war

US stocks accelerated losses on Thursday, with Big Tech and semiconductor stocks leading the market sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. T... Full story

Yahoo Finance • 2 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as tech slides, Wall Street weighs prospects for Iran truce

US stocks accelerated losses on Thursday, with Big Tech and semiconductor stocks leading the market sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. T... Full story

Yahoo Finance • 2 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as Wall Street weighs prospects for Iran truce

US stocks accelerated losses on Thursday as conflicting messages from the US and Iran fueled mounting uncertainty about the prospects for talks to end the Middle East conflict. The S&P 500 (^GSPC) fell 1.5%, while the tech-heavy Nasdaq Co... Full story

Yahoo Finance • 2 months ago

Top Midday Stories: Iran Reportedly Sends Formal Response to US Ceasefire Proposal; Corebridge, Equitable to Merge in $22 Billion All-Stock Deal

All three major US stock indexes were down in late-morning trading on Thursday as investors attempt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 2 months ago

Wave Plunges More Than 50% After Obesity Shot Falls Short

(Bloomberg) -- Wave Life Sciences Ltd. shares plunged their most on record after a single, higher-dose shot of its weight-loss drug failed to meet investor expectations for reducing visceral fat. The medicine, known as WVE-007, is intende... Full story

Yahoo Finance • 2 months ago

Here’s What Boosted Wave Life Sciences Ltd. (WVE) in Q4

Loomis Sayles, an investment management company, released its fourth-quarter 2025 investor letter for “Small Cap Growth Fund”. A copy of the letter is available to download here. The small caps' earnings are reaccelerating in 2025, as the... Full story

Yahoo Finance • 3 months ago

Wave Life Sciences Ltd. (WVE): A Bull Case Theory

We came across a bullish thesis on Wave Life Sciences Ltd. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on WVE. Wave Life Sciences Ltd.'s share was trading at $14.54 as of February 25th. Khosro/Shutterstock... Full story

Yahoo Finance • 3 months ago

Bank of America Predicts Up to 240% Jump for These 2 ‘Strong Buy’ Stocks

The stock market has been treading water so far this year, with the S&P 500 up roughly 1% while the Nasdaq has slipped 1.5%. Tech stocks have struggled to regain last year’s momentum as investors reassess the durability of AI-driven spendi... Full story

Yahoo Finance • 3 months ago

BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)’s Growth, Projecting Peak Sales Above $11B

Wave Life Sciences Ltd. (NASDAQ:WVE) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts.BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)'s Growth, Projecting Peak Sales Above $11B Wave Lif... Full story

Yahoo Finance • 3 months ago

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Wave Life Sciences (NASDAQ:WVE) is one of the 17 biotechnology stocks with more than 50% upside. As of the February 12 closing, consensus sentiment around Wave Life Sciences (NASDAQ:WVE) remained strongly bullish. The stock received cover... Full story

Yahoo Finance • 4 months ago

Microsoft downgraded, Snap upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: B. Riley upgraded Snap (SNAP) to Buy fro... Full story

Yahoo Finance • 4 months ago

Wave Life Sciences price target raised to $50 from $47 at Clear Street

Clear Street raised the firm’s price target on Wave Life Sciences (WVE) to $50 from $47 and keeps a Buy rating on the shares after GSK (GSK) returned the rights to WVE-006 for alpha1-antitrypsin deficiency. The firm views the news as an “o... Full story

Yahoo Finance • 4 months ago

Wave Life Sciences Announces Plans to Accelerate Regulatory Engagement with Full Control of WVE-006 for Alpha-1 Antitrypsin Deficiency

WVE-006 is a first-in-class RNA editing therapeutic candidate designed to correct the root cause of disease for the 200,000 individuals in the U.S. and Europe living with AATD; no currently approved therapies address both lung and liver ma... Full story